- Poster presentation
- Published:
Correlations between plasma concentration of N-terminal pro-brain natriuretic peptide and cardiac function in patients with cardiovascular diseases
Critical Care volume 8, Article number: P56 (2004)
Objective
To demonstrate the relations of the plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) concentration with the severity of heart failure, the underling heart disease and New York Heart Association (NYHA) functional classifications in patients with cardiovascular disease.
Method
Plasma NT-ProBNP concentrations of patients with cardiovascular disease (n = 65) and of normal controls (n = 16) were measured by nonextracted, enzyme-linked, sandwich immunoassay (Elecsys®) after admission. Constructive and functional parameters of heart were measured with echocardiography in 65 patients at the same time.
Result
The plasma NT-ProBNP concentrations of patients were significantly higher than those of normal controls. They also increased according to the severity of heart failure classified by NYHA functional classifications (P < 0.001). The plasma NT-ProBNP concentrations and left ventricular end diastolic volume (LVEDV) also had significant positive correlations with NYHA functional classifications (r = 0.769, P < 0.001 and r = 0.376, P = 0.02, respectively). For NT-proBNP in the diagnosis of heart failure, a level > 200 pg/ml had a sensitivity of 100%, a specificity of 97%, a positive predictive value of 98% and a negative predictive value of 100%.
Conclusion
The plasma levels of NT-ProBNP increase significantly according to the severity of heart failure classified by NYHA functional classifications. The plasma NT-ProBNP concentration is a sensitive biochemical parameter for evaluating the heart function.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zhao, Y., Tian, Y., Gao, W. et al. Correlations between plasma concentration of N-terminal pro-brain natriuretic peptide and cardiac function in patients with cardiovascular diseases. Crit Care 8 (Suppl 1), P56 (2004). https://doi.org/10.1186/cc2523
Published:
DOI: https://doi.org/10.1186/cc2523